IL128317A - A preparation containing mopirocin and chlorhexidine - Google Patents

A preparation containing mopirocin and chlorhexidine

Info

Publication number
IL128317A
IL128317A IL12831797A IL12831797A IL128317A IL 128317 A IL128317 A IL 128317A IL 12831797 A IL12831797 A IL 12831797A IL 12831797 A IL12831797 A IL 12831797A IL 128317 A IL128317 A IL 128317A
Authority
IL
Israel
Prior art keywords
weight
chlorhexidine
composition
mupirocin
acceptable salt
Prior art date
Application number
IL12831797A
Other languages
English (en)
Hebrew (he)
Other versions
IL128317A0 (en
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of IL128317A0 publication Critical patent/IL128317A0/xx
Publication of IL128317A publication Critical patent/IL128317A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12831797A 1996-08-01 1997-07-29 A preparation containing mopirocin and chlorhexidine IL128317A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616208.6A GB9616208D0 (en) 1996-08-01 1996-08-01 Novel Compounds
PCT/EP1997/004165 WO1998005313A1 (en) 1996-08-01 1997-07-29 Composition comprising mupirocin and chlorhexidine

Publications (2)

Publication Number Publication Date
IL128317A0 IL128317A0 (en) 2000-01-31
IL128317A true IL128317A (en) 2001-08-08

Family

ID=10797878

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12831797A IL128317A (en) 1996-08-01 1997-07-29 A preparation containing mopirocin and chlorhexidine

Country Status (21)

Country Link
US (1) US6214866B1 (xx)
EP (1) EP0921791B1 (xx)
JP (1) JP2000517294A (xx)
KR (1) KR20000029678A (xx)
CN (1) CN1231606A (xx)
AR (1) AR008797A1 (xx)
AT (1) ATE207350T1 (xx)
AU (1) AU708688B2 (xx)
BR (1) BR9710899A (xx)
CA (1) CA2262430A1 (xx)
CZ (1) CZ29199A3 (xx)
DE (1) DE69707691T2 (xx)
ES (1) ES2163186T3 (xx)
GB (1) GB9616208D0 (xx)
IL (1) IL128317A (xx)
NO (1) NO990440D0 (xx)
NZ (1) NZ333896A (xx)
PL (1) PL331423A1 (xx)
TR (1) TR199900211T2 (xx)
WO (1) WO1998005313A1 (xx)
ZA (1) ZA976791B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
EP1684772A1 (en) * 2003-11-17 2006-08-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US20060051384A1 (en) 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
CA2599667C (en) * 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
CA2599653A1 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
EP1858506A2 (en) * 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
CA2667307C (en) 2006-10-27 2015-12-01 3M Innovative Properties Company Antimicrobial compositions comprising a c2-c5 lower alcohol, a cationic antimicrobial agent, and a fatty component containing free hydroxyl groups
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
CA2778081A1 (en) * 2009-10-26 2011-05-12 Innovation Technologies, Inc. Devices, methods, and composition for controlling infections
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
WO2017095352A1 (en) 2015-12-01 2017-06-08 Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi Use of wax, olive oil, butter mixture and/ or its combination with varying ratios of boron and/ or derivatives thereof, in treatment of wounds, burns, and skin diseases
BR112018072647A2 (pt) * 2016-05-06 2019-02-19 SaCSh Corp. composições oftálmicas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US4122158A (en) 1976-09-23 1978-10-24 Alza Corporation Topical therapeutic preparations
CA1196284A (en) 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
EP0128228B1 (de) 1983-06-08 1988-01-07 Ibm Deutschland Gmbh Verfahren und Anordnung zur Erzeugung von Impulsen beliebiger Zeitrelation innerhalb unmittelbar aufeinanderfolgender Impulsintervalle mit sehr hoher Genauigkeit und zeitlicher Auflösung
GB8415579D0 (en) 1984-06-19 1984-07-25 Beecham Group Plc Compounds
IT1202193B (it) 1985-10-31 1989-02-02 Pico Glass Spa Cornice porta-immagine
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment

Also Published As

Publication number Publication date
EP0921791A1 (en) 1999-06-16
WO1998005313A1 (en) 1998-02-12
IL128317A0 (en) 2000-01-31
AR008797A1 (es) 2000-02-23
NO990440L (no) 1999-01-29
EP0921791B1 (en) 2001-10-24
DE69707691D1 (de) 2001-11-29
PL331423A1 (en) 1999-07-19
CN1231606A (zh) 1999-10-13
DE69707691T2 (de) 2002-08-01
US6214866B1 (en) 2001-04-10
KR20000029678A (ko) 2000-05-25
CZ29199A3 (cs) 1999-07-14
NO990440D0 (no) 1999-01-29
JP2000517294A (ja) 2000-12-26
ES2163186T3 (es) 2002-01-16
AU3771797A (en) 1998-02-25
CA2262430A1 (en) 1998-02-12
TR199900211T2 (xx) 1999-03-22
ZA976791B (en) 1999-02-09
ATE207350T1 (de) 2001-11-15
NZ333896A (en) 2000-06-23
BR9710899A (pt) 2000-01-11
AU708688B2 (en) 1999-08-12
GB9616208D0 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
EP0921791B1 (en) Composition comprising mupirocin and chlorhexidine
US4524075A (en) Pharmaceutical formulations containing pseudomonic acid
US4474753A (en) Topical drug delivery system utilizing thermosetting gels
WO1992004016A1 (en) Pharmaceutical composition of florfenicol
WO2004108162A3 (en) Controlled release pharmaceutical composition
EP0992509A3 (en) Novel macrolide derivatives
CA1236456A (en) Silver pseudomonate
US4423033A (en) Pharmaceutical compositions
AU707220B2 (en) Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
US5510390A (en) Anti-hypertensive composition and methods of treatment
EP0302836B1 (en) Pharmaceutical compositions for topical use containing miocamycin
CA2256391A1 (en) Anticoagulant peptidyl-arginine aldehyde derivatives
MXPA99001136A (en) Composition comprising mupirocin and chlorhexidine
CA2382654A1 (en) Novel a-500359 derivatives
AP9801235A0 (en) Erythromycin derivatives.
US5985291A (en) Method of treating infections using mupirocin chlorhexidene
EP0238207B1 (en) Bactericidal mixtures
SK5682000A3 (en) Compositions containing thiamphenicol and diclofenac
EP0384722B1 (en) Chemical compositions
EP0154484A2 (en) 7-D-Mandelamido-3-(1-sulfomethyltetrazol-5-YL)Thiomethyl-3-cephem-4-carboxylic acid monosodium salt
JPS63264418A (ja) 安定化された眼科用組成物
JPH0348886B2 (xx)

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees